Conditional TGF-β1 treatment increases stem cell-like cell population in myoblasts

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 3, 2011, Pages 679-690

  Mu, Xiaodong ^a,b   Li, Yong ^a,b,c  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c University of Pittsburgh   (United States)

Author keywords

Dedifferentiation; Multipotency; Skeletal muscle; Stem cell; TGF 1

Indexed keywords

LY ANTIGEN; LY6A PROTEIN, MOUSE; MEMBRANE PROTEIN; MYOD PROTEIN; MYOD1 MYOGENIC DIFFERENTIATION PROTEIN; PAX7 PROTEIN, MOUSE; TRANSCRIPTION FACTOR PAX7; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; ARTICLE; C57BL MOUSE; CELL CULTURE; CELL CYCLE S PHASE; CELL DEDIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL TRANSPLANTATION; CYTOLOGY; DRUG EFFECT; DUCHENNE MUSCULAR DYSTROPHY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETICS; METABOLISM; METHODOLOGY; MOUSE; MOUSE MUTANT; MYOBLAST; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; TRANSPLANTATION; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; ANTIGENS, LY; CELL DEDIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL TRANSPLANTATION; CELLS, CULTURED; GENE EXPRESSION; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MICE, SCID; MICROSCOPY, FLUORESCENCE; MUSCULAR DYSTROPHY, DUCHENNE; MYOBLASTS; MYOD PROTEIN; PAX7 TRANSCRIPTION FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; S PHASE; STEM CELLS; TRANSFORMING GROWTH FACTOR BETA1;

MUS;

EID: 79953323286     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01042.x     Document Type: Article

References (66)

1. Qu-Petersen Z, Deasy B, Jankowski R, et al Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol. 2002; 157: 851-64.
2. Deasy BM, Li Y, Huard J. Tissue engineering with muscle-derived stem cells. Curr Opin Biotechnol. 2004; 15: 419-23.
3. Beauchamp JR, Morgan JE, Pagel CN, et al Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J Cell Biol. 1999; 144: 1113-22.
4. Quintero AJ, Wright VJ, Fu FH, et al Stem cells for the treatment of skeletal muscle injury. Clin Sports Med. 2009; 28: 1-11.
5. Gussoni E, Soneoka Y, Strickland CD, et al Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature. 1999; 401: 390-4.
6. Lo DC, Allen F, Brockes JP. Reversal of muscle differentiation during urodele limb regeneration. Proc Natl Acad Sci USA. 1993; 90: 7230-4.
7. Kumar A, Velloso CP, Imokawa Y, et al Plasticity of retrovirus-labelled myotubes in the newt limb regeneration blastema. Dev Biol. 2000; 218: 125-36.
8. Echeverri K, Tanaka EM. Mechanisms of muscle dedifferentiation during regeneration. Semin Cell Dev Biol. 2002; 13: 353-60.
9. McGann CJ, Odelberg SJ, Keating MT. Mammalian myotube dedifferentiation induced by newt regeneration extract. Proc Natl Acad Sci USA. 2001; 98: 13699-704.
10. Ding S, Schultz PG. A role for chemistry in stem cell biology. Nat Biotechnol. 2004; 22: 833-40.
11. Chen S, Zhang Q, Wu X, et al Dedifferentiation of lineage-committed cells by a small molecule. J Am Chem Soc. 2004; 126: 410-1.
12. Duckmanton A, Kumar A, Chang YT, et al A single-cell analysis of myogenic dedifferentiation induced by small molecules. Chem Biol. 2005; 12: 1117-26.
13. Odelberg SJ, Kollhoff A, Keating MT. Dedifferentiation of mammalian myotubes induced by msx1. Cell. 2000; 103: 1099-109.
14. Chen X, Mao Z, Liu S, et al Dedifferentiation of adult human myoblasts induced by ciliary neurotrophic factor in vitro. Mol Biol Cell. 2005; 16: 3140-51.
15. Levesque M, Gatien S, Finnson K, et al Transforming growth factor: beta signaling is essential for limb regeneration in axolotls. PLoS ONE. 2007; 2: e1227.
16. Jian H, Shen X, Liu I, et al Smad3-dependent nuclear translocation of beta-catenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. Genes Dev. 2006; 20: 666-74.
17. Campanaro S, Picelli S, Torregrossa R, et al Genes involved in TGF beta1-driven epithelial-mesenchymal transition of renal epithelial cells are topologically related in the human interactome map. BMC Genomics. 2007; 8: 383-97.
18. Abbate M, Zoja C, Morigi M, et al Transforming growth factor-beta1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis. Am J Pathol. 2002; 161: 2179-93.
19. Zavadil J, Bitzer M, Liang D, et al Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc Natl Acad Sci USA. 2001; 98: 6686-91.
20. Grisanti S, Esser P, Schraermeyer U. Retinal pigment epithelial cells: autocrine and paracrine stimulation of extracellular matrix contraction. Graefes Arch Clin Exp Ophthalmol. 1997; 235: 587-98.
21. Mani SA, Guo W, Liao MJ, et al The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133: 704-15.
22. Shen W, Li Y, Zhu J, et al Interaction between macrophages, TGF-beta1, and the COX-2 pathway during the inflammatory phase of skeletal muscle healing after injury. J Cell Physiol. 2008; 214: 405-12.
23. Li Y, Foster W, Deasy BM, et al Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol. 2004; 164: 1007-19.
24. Olson EN, Sternberg E, Hu JS, et al Regulation of myogenic differentiation by type beta transforming growth factor. J Cell Biol. 1986; 103: 1799-805.
25. Caffrey JM, Brown AM, Schneider MD. Ca2+ and Na+ currents in developing skeletal myoblasts are expressed in a sequential program: reversible suppression by transforming growth factor beta-1, an inhibitor of the myogenic pathway. J Neurosci. 1989; 9: 3443-53.
26. Massague J, Cheifetz S, Endo T, et al Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc Natl Acad Sci USA. 1986; 83: 8206-10.
27. Watabe T, Miyazono K. Roles of TGF-beta family signaling in stem cell renewal and differentiation. Cell Res. 2009; 19: 103-15.
28. Peiffer I, Barbet R, Zhou YP, et al Use of xenofree matrices and molecularly-defined media to control human embryonic stem cell pluripotency: effect of low physiological TGF-beta concentrations. Stem Cells Dev. 2008; 17: 519-33.
29. Gharaibeh B, Lu A, Tebbets J, et al Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique. Nat Protoc. 2008; 3: 1501-9.
30. Johnstone B, Hering TM, Caplan AI, et al In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res. 1998; 238: 265-72.
31. Zheng B, Cao B, Li G, et al Mouse adipose-derived stem cells undergo multilineage differentiation in vitro but primarily osteogenic and chondrogenic differentiation in vivo. Tissue Eng. 2006; 12: 1891-901.
32. Zuk PA, Zhu M, Mizuno H, et al Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001; 7: 211-28.
33. Li Y, Huard J. Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol. 2002; 161: 895-907.
34. Asakura A. Stem cells in adult skeletal muscle. Trends Cardiovasc Med. 2003; 13: 123-8.
35. Lu A, Cummins JH, Pollett JB, et al Isolation of myogenic progenitor populations from Pax7-deficient skeletal muscle based on adhesion characteristics. Gene Ther. 2008; 15: 1116-25.
36. Zammit PS, Relaix F, Nagata Y, et al Pax7 and myogenic progression in skeletal muscle satellite cells. J Cell Sci. 2006; 119: 1824-32.
37. Seale P, Sabourin LA, Girgis-Gabardo A, et al Pax7 is required for the specification of myogenic satellite cells. Cell. 2000; 102: 777-86.
38. Skapek SX, Rhee J, Spicer DB, et al Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science. 1995; 267: 1022-4.
39. Derer W, Easwaran HP, Leonhardt H, et al A novel approach to induce cell cycle reentry in terminally differentiated muscle cells. FASEB J. 2002; 16: 132-3.
40. Tanaka EM, Gann AA, Gates PB, et al Newt myotubes reenter the cell cycle by phosphorylation of the retinoblastoma protein. J Cell Biol. 1997; 136: 155-65.
41. Velloso CP, Simon A, Brockes JP. Mammalian postmitotic nuclei reenter the cell cycle after serum stimulation in newt/mouse hybrid myotubes. Curr Biol. 2001; 11: 855-8.
42. Deasy BM, Gharaibeh BM, Pollett JB, et al Long-term self-renewal of postnatal muscle-derived stem cells. Mol Biol Cell. 2005; 16: 3323-33.
43. Tintignac LA, Sirri V, Leibovitch MP, et al Mutant MyoD lacking Cdc2 phosphorylation sites delays M-phase entry. Mol Cell Biol. 2004; 24: 1809-21.
44. Ishido M, Kami K, Masuhara M. Localization of MyoD, myogenin and cell cycle regulatory factors in hypertrophying rat skeletal muscles. Acta Physiol Scand. 2004; 180: 281-9.
45. Li Y, Li J, Zhu J, et al Decorin gene transfer promotes muscle cell differentiation and muscle regeneration. Mol Ther. 2007; 15: 1616-22.
46. Edmondson DG, Olson EN. Helix-loop-helix proteins as regulators of muscle-specific transcription. J Biol Chem. 1993; 268: 755-8.
47. Guo K, Wang J, Andres V, et al MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol. 1995; 15: 3823-9.
48. Halevy O, Novitch BG, Spicer DB, et al Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science. 1995; 267: 1018-21.
49. Ishido M, Kami K, Masuhara M. In vivo expression patterns of MyoD, p21, and Rb proteins in myonuclei and satellite cells of denervated rat skeletal muscle. Am J Physiol Cell Physiol. 2004; 287: C484-93.
50. Fuchtbauer EM, Westphal H. MyoD and myogenin are coexpressed in regenerating skeletal muscle of the mouse. Dev Dyn. 1992; 193: 34-9.
51. Jin Y, Murakami N, Saito Y, et al Expression of MyoD and myogenin in dystrophic mice, mdx and dy, during regeneration. Acta Neuropathol. 2000; 99: 619-27.
52. Peault B, Rudnicki M, Torrente Y, et al Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther. 2007; 15: 867-77.
53. Urish KL, Vella JB, Okada M, et al Antioxidant levels represent a major determinant in the regenerative capacity of muscle stem cells. Mol Biol Cell. 2009; 20: 509-20.
54. Lecoeur L, Ouhayoun JP. In vitro induction of osteogenic differentiation from non-osteogenic mesenchymal cells. Biomaterials. 1997; 18: 989-93.
55. Ikezawa M, Cao B, Qu Z, et al Dystrophin delivery in dystrophin-deficient DMDmdx skeletal muscle by isogenic muscle-derived stem cell transplantation. Hum Gene Ther. 2003; 14: 1535-46.
56. Torrente Y, Tremblay JP, Pisati F, et al Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. J Cell Biol. 2001; 152: 335-48.
57. Odelberg SJ. Inducing cellular dedifferentiation: a potential method for enhancing endogenous regeneration in mammals. Semin Cell Dev Biol. 2002; 13: 335-43.
58. Oustanina S, Hause G, Braun T. Pax7 directs postnatal renewal and propagation of myogenic satellite cells but not their specification. EMBO J. 2004; 23: 3430-9.
59. Miettinen PJ, Ebner R, Lopez AR, et al TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol. 1994; 127: 2021-36.
60. Zavadil J, Bottinger EP. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene. 2005; 24: 5764-74.
61. Lee KS, Kim HJ, Li QL, et al Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol. 2000; 20: 8783-92.
62. Zammit PS, Heslop L, Hudon V, et al Kinetics of myoblast proliferation show that resident satellite cells are competent to fully regenerate skeletal muscle fibers. Exp Cell Res. 2002; 281: 39-49.
63. Davis PK, Ho A, Dowdy SF. Biological methods for cell-cycle synchronization of mammalian cells. Biotechniques. 2001; 30: 1322-6, 8, 30-1.
64. Kitzmann M, Fernandez A. Crosstalk between cell cycle regulators and the myogenic factor MyoD in skeletal myoblasts. Cell Mol Life Sci. 2001; 58: 571-9.
65. Pajalunga D, Mazzola A, Salzano AM, et al Critical requirement for cell cycle inhibitors in sustaining nonproliferative states. J Cell Biol. 2007; 176: 807-18.
66. Dang CM, Beanes SR, Lee H, et al Scarless fetal wounds are associated with an increased matrix metalloproteinase-to-tissue-derived inhibitor of metalloproteinase ratio. Plast Reconstr Surg. 2003; 111: 2273-85.